In a Livestreamed Real-World Assessment, MedGPT's AI Doctors Rival Diagnostic Accuracy of China's Leading Doctors...
Lark Health, the leading AI-powered digital care coaching company for the prevention and management of chronic conditions, and Desert Oasis Healthcare (DOHC), a member of Heritage Provider Network, today announced their expanded partnership where DOHC will offer Lark's Prevention program and CDC-recognized Diabetes Prevention program to their patients....
Technology enables inference of subjective outcomes from routinely collected data...
Transforming Heart Failure Management: Astellas, Eko Health & Welldoc Collaborate...
Optina Diagnostics' pioneering pivotal REPHRASE study, currently underway, is poised to revolutionize the diagnosis and management of Alzheimer's Disease (AD). This landmark study is focused on validating the novel awAIr™-Cerebral Amyloid Status (CAS) test, an innovative tool intended to provide physicians with definitive information about Alzheimer's pathology, enabling improved management of cognitive impairments....
DiamiR Biosciences, a developer of innovative non-invasive blood-based diagnostic tests for brain health and other diseases, today announced that it has entered into an agreement with JADBio to utilize its Automated Machine Learning (AutoML) Platform and Services for development of predictive models based on DiamiR's microRNA panels and other factors for risk assessment in Alzheimer's disease and Rett syndrome....
Ultromics, a leading health technology company advancing a novel approach for detecting heart failure and its phenotypes, announced today the assignment of a new outpatient code by the Centers for Medicare and Medicaid Services (CMS), for its flagship product, EchoGo® Heart Failure. HCPCS code C9786 can now be used for billing artificial intelligence to aid the detection of Heart Failure with Preserved Ejection Fraction (HFpEF). HCPCS code C9786 can now be used for billing artificial intell...
Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the AVEIR™ dual chamber (DR) leadless pacemaker system, the world's first dual chamber leadless pacing system that treats people with abnormal or slow heart rhythms. With more than 80% of people who need a pacemaker requiring pacing in two chambers of the heart (both the right atrium and right ventricle), the approval significantly increases access to leadless pacing for millions of people across the U.S.[i]...
Inaugurated by the Minister for Finance, Health, Medical & Family Welfare, Government of Telangana ...
Recent study conducted by Seoul National University Hospital provides strong evidence that high-accuracy AI model improves radiologists' chest X-ray analysis performance...
